Form 8-K - Current report:
SEC Accession No. 0001140361-25-019282
Filing Date
2025-05-15
Accepted
2025-05-15 16:12:40
Documents
14
Period of Report
2025-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ef20049144_8k.htm   iXBRL 8-K 69462
  Complete submission text file 0001140361-25-019282.txt   249921

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imcr-20250515.xsd EX-101.SCH 4454
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20250515_def.xml EX-101.DEF 17585
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20250515_lab.xml EX-101.LAB 26483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20250515_pre.xml EX-101.PRE 19770
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20049144_8k_htm.xml XML 6494
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 25953146
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)